What claims are risky for men care in the U.S., and how do we avoid drug claims?

In the U.S., risky claims for men care include implying treatment of conditions like acne or hair loss. Avoid drug claims by sticking to cosmetic benefits such as cleansing, moisturizing, or improving appearance.

US buyer view Launch planning Updated: February 6, 2026
Chat on WhatsApp
Best for
US brand owners, Amazon/FBA sellers, distributors, and private label buyers
Core intent
Who submits, what data is needed, and how to plan timelines before production

Quick Answer (for busy buyers)

Here’s the buyer-first summary. If your brand name is on the label, you usually act as the responsible person and must ensure the listing is submitted and kept current.

  • In the U.S., men care products are regulated by the FDA as cosmetics, so claims that imply drug-like effects are high-risk.
  • Risky claims include treating acne, preventing hair loss, or altering body functions, as these can classify products as drugs.
  • To avoid drug claims, use language focused on cosmetic purposes: for example, say ‘refreshes skin’ instead of ‘treats oily skin’ or ‘soothes irritation’ rather than ‘heals wounds.’ As an OEM, we integrate claim validation early in the workflow.
  • During formulation, we ensure ingredients align with cosmetic definitions and conduct safety tests like dermatological trials and stability checks to support claims.
  • Documentation includes Certificates of Analysis (COA) and compliance statements for FDA guidelines.
  • MOQ typically starts at 5,000 units per SKU, but can increase if custom claim testing is required.
  • Sampling timeline is 2-4 weeks, allowing time for claim substantiation and efficacy testing.
  • Packaging must be reviewed to avoid misleading labels; we check artwork for unsubstantiated claims.
  • Lead time for production may extend by 1-2 weeks for regulatory scrutiny.
  • We support with necessary testing and documents, but ultimate compliance and claim approval are the brand’s responsibility, so consult legal experts.
Buyer outcome
A launch-ready compliance plan: inputs collected, roles assigned, and update cadence defined.
Most common blocker
Missing facility information + inconsistent ingredient/label snapshots across SKUs.
⚠️
This page is a practical buyer guide. For definitive requirements and updates, use FDA resources and qualified regulatory counsel.
  • Our team will answer your inquiries within 8 hours.
  • Your information will be kept strictly confidential.

Request received

Thanks — we’ve received your request. Our team will follow up shortly. we typically reply within 8 hours (often sooner).